fura-2 has been researched along with montelukast in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, R; Feldman, C; Gravett, CM; Steel, HC; Theron, AJ; Tintinger, GR | 2 |
2 other study(ies) available for fura-2 and montelukast
Article | Year |
---|---|
Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetates; Calcium; Chemotactic Factors; Cyclic AMP; Cyclopropanes; Dose-Response Relationship, Drug; Fluorescent Dyes; Fura-2; Humans; In Vitro Techniques; Leukotriene Antagonists; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Pancreatic Elastase; Quinolines; Reactive Oxygen Species; Receptors, Leukotriene; Sulfides | 2009 |
Leukotrienes C4 and D4 sensitize human neutrophils for hyperreactivity to chemoattractants.
Topics: Acetates; Adult; Chemotactic Factors; Cyclopropanes; Fluorescent Dyes; Fura-2; Humans; Inflammation; Leukotriene Antagonists; Leukotriene C4; Leukotriene D4; Matrix Metalloproteinase 8; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Quinolines; Sulfides; Superoxides | 2009 |